MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT)MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT)MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT)

MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT)

No trades
See on Supercharts
Market capitalization
‪10.08 M‬USD
−15.0970USD
‪−29.77 M‬USD
‪2.15 M‬
Beta (1Y)
1.18

About MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT)

CEO
Walter V. Klemp
Headquarters
Houston
Employees (FY)
18
ISIN
US60855D3098
FIGI
BBG00JVRFDT8
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0K2H is 4.3500 USD — it has increased by 1.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) stocks are traded under the ticker 0K2H.
MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
0K2H stock is 1.56% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) there?
One year price forecast for MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) has a max estimate of 40.0000 USD and a min estimate of 20.0000 USD.
0K2H earnings for the last quarter are −2.85 USD per share, whereas the estimation was −3.35 USD resulting in a 14.93% surprise. The estimated earnings for the next quarter are −3.23 USD per share. See more details about MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) earnings.
Yes, you can track MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
0K2H stock has fallen by 17.25% compared to the previous week, the month change is a 96.33% fall, over the last year MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) has showed a 98.66% decrease.
0K2H net income for the last quarter is ‪−10.27 M‬ USD, while the quarter before that showed ‪−5.61 M‬ USD of net income which accounts for −83.08% change. Track more MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) financial stats to get the full picture.
Today MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) has the market capitalization of ‪10.08 M‬, it has decreased by 7.34% over the last week.
No, 0K2H doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0K2H shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
0K2H reached its all-time high on Feb 16, 2018 with the price of 3780.0000 USD, and its all-time low was 4.3500 USD and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 18.00 employees. See our rating of the largest employees — is MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) stock shows the sell signal. See more of MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) future price: according to them, 0K2H price has a max estimate of 40.00 USD and a min estimate of 20.00 USD. Read a more detailed MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) forecast: see what analysts think of MOLECULIN BIOTECH INC COM USD0.001(POST REV SPLIT) and suggest that you do with its stocks.